以NF-κB 信号途径治疗前列腺癌：该方法可行吗？

Title:Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?

Volume: 17 Issue: 3

Author(s): Daniela Verzella, Mariafausta Fischietti, Daria Capece, Davide Vecchiotti, Filippo Del Vecchio and Germana Cicciarelli Valentina Mastroiaco, Alessandra Tessitore, Edoardo Alesse, Francesca Zazzeroni

Affiliation:

关键词: 前列腺癌，NF-κB，IKK，NF-κB抑制剂，蛋白酶体抑制剂，IKK抑制剂，抗炎药物。

摘要: Rel/NF-κB transcription factors are key regulators of genes implicated in inflammatory and immune activation, cell growth and protection from apoptosis. Constitutive activation of NF-κB has been observed in several types of cancers. Recently, it has been shown that inflammation and cancer are molecularly linked by means of NF-κB. During prostate cancer progression, NF-κB promotes cell survival, tumor invasion, metastasis and chemoresistance. NF-κB constitutive activation has been frequently demonstrated in primary prostate cancers and it correlates with loss of androgen receptor expression and castration-resistant phenotypes. Indeed, inhibition of NF-κB pathway may reduce the oncogenic effects mediated by chronic inflammatory response. Therefore, NF-κB represents a hopeful target for the treatment of prostate cancer due to its role in oncogenesis and chemoresistance. Here, the current knowledge about the roles of NF-κB signaling pathway in prostate tumorigenesis is discussed, taking into consideration the potentiality and effectiveness of NF-κB inhibitors as therapeutic agents for prostate cancer.

Cite this article as:

Daniela Verzella, Mariafausta Fischietti, Daria Capece, Davide Vecchiotti, Filippo Del Vecchio and Germana Cicciarelli Valentina Mastroiaco, Alessandra Tessitore, Edoardo Alesse, Francesca Zazzeroni , Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?, Current Drug Targets 2016; 17 (3) . https://dx.doi.org/10.2174/1389450116666150907100715